Citadel Advisors
PMD

Citadel Advisors’s Psychemedics Corporation PMD Stock Holding History

Citadel Advisors’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-21,509
Closed -$49.7K – 15662
2024
Q3 		$49.7K Buy
21,509
+8,869
+70% +$19.9K ﹤0.01% 11925
2024
Q2 		$30.6K Sell
12,640
-5,316
-30% -$13.5K ﹤0.01% 12252
2024
Q1 		$52.6K Buy
17,956
+1,756
+11% +$5.57K ﹤0.01% 12133
2023
Q4 		$48K Sell
16,200
-4,238
-21% -$11.3K ﹤0.01% 11821
2023
Q3 		$81.1K Buy
+20,438
New +$91.2K ﹤0.01% 11161

Other funds holding PMD

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
SMP
Santa Monica Partners Palm Beach Gardens, Florida $179M AUM 19.18% 1-Year Est. Return

Citadel Advisors's PMD Position: Q4 2024 in Review

Citadel Advisors sold out of Psychemedics Corporation (PMD) in Q4 2024, closing a stake of 21,509 shares — an estimated $49.7K sold.

Citadel Advisors first reported a position in PMD in Q3 2023 and held it in 5 quarters. The position peaked at $81.1K in Q3 2023. 3 funds tracked by Wall St. Rank hold PMD as of Q4 2024.

  • Citadel Advisors reported no remaining Psychemedics Corporation position as of Q4 2024 after selling out during the quarter.
  • Citadel Advisors sold 21,509 Psychemedics Corporation shares in Q4 2024, an estimated $49.7K.
  • Citadel Advisors first reported a position in Psychemedics Corporation in Q3 2023 and held it in 5 quarters.
  • Citadel Advisors's Psychemedics Corporation position peaked at $81.1K in Q3 2023.
  • 3 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q4 2024.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.